Clinical Trial Update: Phase II Trial to Compare the Safety of Two Chemotherapy Plus Trastuzumab Regimens as Adjuvant Therapy for HER2-positive Breast Cancer (Study P05048) [Phase 2]

View source ↗

Summary

Phase II study comparing the safety of two chemotherapy regimens plus trastuzumab as adjuvant therapy for HER2-positive breast cancer has completed, with result…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Trastuzumab (trastuzumab)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Breast Neoplasm | Phase 2 | Status: COMPLETED | Results posted: 2011-10-03